Transcode Therapeutics, Inc. · NASDAQ:RNAZ

Daniel Eduardo Katzman reported a 5.16% stake in Transcode Therapeutics, Inc. (Schedule 13G)

Event Jul 23, 2026 · Filed Jul 28, 2026

Daniel Eduardo Katzman reported a 5.16% stake in Transcode Therapeutics, Inc., 155,611 shares, as a passive investor on Jul 23, 2026. Filed Jul 28, 2026 (Schedule 13G).

Stake
5.16%
Shares
155,611
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Daniel Eduardo Katzman5.16%155,611

Source

View original at SEC

Related